Several brokerages have recently shared their views on SBI Life Insurance. Here’s a summary of what they are saying:
- HSBC: HSBC has maintained its buy call on SBI Life with a share price target of ₹1,940, indicating a 13.3% upside from the CMP of ₹1,711.70. The brokerage highlights new product launches with a focus on pure protection and expects the impact to be visible from Q3.
- Macquarie: Macquarie has maintained an outperform rating with a target price of ₹1,830, implying a 7% upside from the CMP of ₹1,711.70. Macquarie noted that Q2 VNB was in line, but the high base effect led to weak APE growth. The VNB growth guidance has been cut to 12-15% for FY25, but the brokerage sees outperformance due to inexpensive valuations.
Disclaimer: This article is for informational purposes only and does not constitute financial advice. Please consult a qualified financial advisor before making any investment decisions.
